New York, April 25, 2018 -- Pyrogen is a type of microbial and non-microbial substance that causes fever. Hence, pyrogen testing is conducted to measure the presence of pyrogen that causes fever. Medical devices manufacturers and pharmaceutical companies also focus on conducting pyrogen testing to assess the concentration level of pyrogen, to ensure that it is within the prescribed limit.
Moreover, regulatory bodies across the globe are also introducing regulations to ensure public safety. Majority of the countries have also made it mandatory for manufacturers to ensure that concentration limit of pyrogen does not exceed the recommended level.
Pyrogen Testing Market Research Report Overview @ https://www.persistencemarketresearch.com/market-research/pyrogen-testing-market.asp
The market for pyrogen testing is also being driven by the recent developments in biotechnology and pharmaceutical industry. Various types of test are being used by companies for testing the level of pyrogen. Companies are also investing in the research and development activities and quality assurance to ensure producing quality drugs. Technological advancement and initiative by governments of different countries for controlling the increasing prevalence of various diseases are also resulting in the growth of pyrogen testing.
Most widely known pyrogens are Lipopolysaccharides, which are considered as cell wall components of gram-negative bacteria. Well-established research and development facility and government support are also resulting in the development of advanced medical devices and novel drugs.
As per the report by Persistence Market Research (PMR), the global market for pyrogen testing is likely to witness robust growth during the forecast period 2017-2024. Towards the end of 2024, the global pyrogen testing market is projected to exceed US$ 1,000 Million revenue.
Request Sample Report @ https://www.persistencemarketresearch.com/samples/4259
Pyrogen Testing to Find Largest Application in Medical Devices
Based on the application, pyrogen testing is expected to find the largest application in medical devices in the global pyrogen testing market. By the end of 2024, medical devices are estimated to bring in more than US$ 200 Million revenue.
On the basis of test type, Limulus Amebocyte Lysate (LAL) is likely to witness the highest growth during 2017-2024. LAL test type is projected to surpass US$ 800 million revenue by 2024 end.
In terms of the end user, the pharmaceutical industry is expected to emerge as the largest user of pyrogen testing in the global market for pyrogen testing. The pharmaceutical industry is estimated to reach close to US$ 500 Million revenue by the end of the forecast period.
Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/market-research/pyrogen-testing-market/toc
North America to Remain Dominant in the Global Pyrogen Testing Market
Region-wise, North America is likely to lead the global market for pyrogen testing throughout the forecast period. North America is projected to bring in more than US$ 500 Million revenue by 2024 end. Discovery and development of new drugs, rise in a number of biologic products, and increasing investment by government in healthcare and pharmaceutical industry are some of the factors driving the growth of the pyrogen testing market in the region. However, stringent regulations and approval policies are likely to restrict the growth of the market in North America.
Leading Players in the Global Pyrogen Testing Market
Some of the leading companies in the global market for pyrogen testing are Thermo Fisher Scientific, Inc., Associates of Cape Cod, Inc., GenScript, Merck & Co., Inc., Charles River Laboratories International, Inc., Lonza Group, Microcoat Biotechnologie GmbH, Hyglos GmbH, and Wako Chemicals USA, Inc.
Get full Report Now https://www.persistencemarketresearch.com/checkout/4259
Persistence Market Research Overview
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact
Ashwani Bhagat
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
Email: [email protected]
PMR Latest News: https://www.persistencemarketresearch.com/news


Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Bain Capital Secures RBI Approval to Acquire Up to 41.7% Stake in Manappuram Finance
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer
Anthropic’s Claude AI Reportedly Used in U.S. Operation to Capture Nicolas Maduro
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
OpenAI Hires OpenClaw Creator Peter Steinberger to Advance Next-Generation AI Agents
Warner Bros. Discovery Weighs Renewed Sale Talks With Paramount Skydance Amid Netflix Deal Review
Mitsui Kinzoku Stock Surges to Record High After Profit Forecast Upgrade and Dividend Increase
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
How Marco Pharma International Preserves German Homeopathic Traditions in America
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development 



